In February, the U.S.
Food & Drug Administration (FDA) announced plans to pilot new technologies including blockchain, to help in the track and trace of pharmaceuticals. Today IBM, Walmart, Merck and KPMG
announced that they’re working together on an FDA blockchain interoperability pilot. There are a total of 20 FDA pilot projects.
The FDA started the program to help companies to comply with DSCSA legislation, which is coming into force in phases. This year there’s a deadline to enable the tracing of returned pharmaceuticals to ensure they’re not
counterfeits. The FDA pilots are targeted at more distant deadlines.
There are concerns that some solutions designed to meet the 2019 deadline may not be adaptable for the 2023 targets. And before the FDA set up the pilot program, some had questioned whether the
2023 DSCSA deadline for interoperability is achievable at all.
Article continues …
Want the full story? Pro subscribers get complete articles, exclusive industry analysis, and early access to legislative updates that keep you ahead of the competition. Join the professionals who are choosing deeper insights over surface level news.
